Monday, May 10, 2010

• Pharmaceutical Companies Earned Over $3 Billion on H1N1 Vaccine: Report --- NEW YORK, NY
  Posted at 2:16 PM
  

  NEW YORK, NY -- (Marketwire) -- 05/10/10 -- Actual revenues earned on H1N1 'swine flu' vaccines may not have reached the levels predicted by some optimistic industry executives and analysts last year, but the vaccines boosted the bottom line of several pharmaceutical companies in an otherwise tough year, according to healthcare market research publisher Kalorama Information. Makers of H1N1 vaccines reported sales of $3.3 billion in 2009, according to company reports reviewed for its title, "H1N1 'Swine Flu' ... read more